Start date: 2004-03-01, End date: 2009-08-31
The main objective of this 4 years IP is the development, up to clinical phase I, of a specific HIV microbicide for the prevention of sexual transmission/acquisition of HIV, based on the interruption of viral replication at the mucosal level. Some members of a new class of non...
Record Number: 75277
Last updated on: 2010-12-15